Cash flows from investing activities:
Purchases of property &
equipment, net (2,268,489) (1,378,541)
Proceeds from sale of property &
equipment - 20,000
Purchases of available-for-sale
securities (3,964,561) (5,482,883)
Maturities of available-for-sale
securities 4,608,000 5,365,000
Cash paid for acquisition (3,337,103) -
Net cash used in
investing activities (4,962,153) (1,476,424)
Cash flows from financing activities:
Payments on long-term debt and
capital leases (292,792) (275,468)
Proceeds from stock option exercises 169,873 83,843
Net proceeds from private
placement of common shares 15,317,002 -
Net cash provided by
(used in) financing
activities 15,194,083 (191,625)
Effect of exchange rate changes on cash (79,882) 35,291
Net increase (decrease) in cash and
cash equivalents 2,339,856 (11,616,827)
Cash and cash equivalents - beginning
of period 14,890,383 27,432,948
Cash and cash equivalents - end of
period $17,230,239 $15,816,121
| SOURCE AtriCure, Inc. Copyright©2007 PR Newswire. All rights reserved |